
News|Videos|March 11, 2025
CDMO Partnership Reimagined – Novartis Contract Manufacturing
Advertisement
To ensure the development and reliable supply of medicines to patients around the world, pharmaceutical and biotech companies increasingly rely on CDMOs, their capabilities and their output. How do you choose an outsourcing partner that will meet your high expectations, not only in the short term, but throughout the lifetime of your product? Read more
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
2
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
3
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
4
Vetter Announces Plan to Build Manufacturing Site in Germany with €1.5 Billion CDMO Investment
5




